Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
Dig Dis Sci
; 63(10): 2714-2721, 2018 10.
Article
in En
| MEDLINE
| ID: mdl-29948562
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Enzyme-Linked Immunosorbent Assay
/
Immunoassay
/
Inflammatory Bowel Diseases
/
Point-of-Care Systems
/
Adalimumab
/
Infliximab
/
Antibodies
Type of study:
Diagnostic_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Dig Dis Sci
Year:
2018
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos